You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2024

Details for Patent: 8,022,054


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,022,054 protect, and when does it expire?

Patent 8,022,054 protects ZTALMY and is included in one NDA.

This patent has twenty-three patent family members in thirteen countries.

Summary for Patent: 8,022,054
Scope and claims summary:
Title:Liquid ganaxolone formulations and methods for the making and use thereof
Abstract: In certain embodiments, the invention is directed to composition comprising stable particles comprising ganaxolone, wherein the volume weighted median diameter (D50) of the particles is from about 50 nm to about 500 nm.
Inventor(s): Shaw; Kenneth (Weston, CT), Zhang; Mingbao (Stamford, CT)
Assignee: Marinus Pharmaceuticals (Branford, CT)
Application Number:11/605,700
Patent Claim Types:
see list of patent claims
Formulation; Compound;

Drugs Protected by US Patent 8,022,054

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Marinus ZTALMY ganaxolone SUSPENSION;ORAL 215904-001 Jun 1, 2022 RX Yes Yes 8,022,054 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,022,054

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO) 3071 ⤷  Subscribe
Australia 2006318349 ⤷  Subscribe
Canada 2631233 ⤷  Subscribe
China 101583620 ⤷  Subscribe
China 106667918 ⤷  Subscribe
Eurasian Patent Organization 017290 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.